Approximately 40% of T-LGLL patients have activating somatic mutations in STAT3 [37], and a small percentage of T-LGLL patients have activating STAT5b somatic mutations [41]. The gene discussed is STAT5B; the disease is T-cell large granular lymphocyte leukemia.